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1. Introduction
Stroke is one of the major health care problems in the world today. It is the third leading
cause of mortality in the western countries and the most common cause of mortality of any
neurological disorder. Incidence of stroke is 160 per 100,000 population per year; 40 percent
of  victims require some type of  special  services and 10 percent require total  care.  [1,  2]
Consequently, stroke rehabilitation places a large drain on national health care resources.
A significant proportion of strokes are ischemic in nature, one of leading causes for which
is internal carotid artery (ICA) atherosclerosis. It is estimated that 20-25 percent of all strokes
can be attributed directly to carotid bifurcation atherosclerosis. [1, 2]
Both internal carotid artery endarterectomy and carotid stenting in patients with preopera‐
tive ocular or cerebral embolic events are well established as procedures that reduce the
risk of future ischaemic events. [3-7] In addition to the management of hypertension and
commencement of antiplatelet and statin therapy, these interventions form the corner stone
of stroke prevention policy in patients with significant ICA stenosis. As it is recognised that
a significant proportion of patients have a disabling embolic stroke attributable to severe
ICA stenosis without any prior symptoms, [8, 9] it would be advantageous if patients who
are at highest risk of stroke from ICA stenosis could be identified and treated in advance
of any ischaemic neurological events.
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2. Atherosclerotic plaque morphology
Atherosclerotic plaques are not static lesions; they undergo dynamic changes in their size and
morphological characteristics. These changes manifest themselves as changes in plaque
volume and consistency, otherwise known as plaque progression and regression. These, together
with adaptive responses of the arterial wall, determine the degree of stenosis in the diseased
artery. [10-12] This degree of stenosis is the measurable clinical finding which, together with
timing and nature of symptoms and co-morbidities, correlates with the risk of developing
further neurological events. [13]
Over the last 20 years a lot has been learned about the morphological characteristics of an
atherosclerotic plaque responsible for plaque progression and instability. [10-12] Morpholog‐
ical characteristics of atherosclerotic plaques can be discussed in the context of plaque surface
characteristics and the composition of the atherosclerotic lesion.
3. Plaque surface characteristics
Julian et al in 1963 were the first to discuss the issue of carotid plaque ulceration. They reported
17 cases of macroscopic plaque ulceration with thrombosis in the ulcer crater and suggested
this as a source for embolisation. [12] Ulceration has been described as an observable disruption
of intima exposing the adjacent atheromatous plaque or media [13] (figure 1).





Figure 1. A carotid endarterectomy specimen containing a large ulcer which is associated with intra-plaque haemor‐
rhage.
There has been conflicting evidence regarding the significance of plaque ulceration in the
evolution of symptomatic disease. In a large study, Imparato et al did not find any significant
difference in the incidence of ulceration between symptomatic and asymptomatic groups.
[14-16]
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Other researchers have found a definite increase in the incidence of plaque ulceration in
patients with symptomatic carotid artery disease. Most notably, following review of 593
angiograms in the North American Symptomatic Carotid Endarterectomy Trial (NASCET), 34
percent of medically treated patients were found to have ulcerated plaques with reasonable
certainty; this figure was 36 percent for those assigned to surgery. At 2 years, 30 percent of the
medically treated group with ulceration had suffered a non-fatal stroke or vascular death
compared to only 17 percent of those without plaque ulceration [17].
One reason for this difference may be the time interval between the duration of symptoms and
surgery in some of the studies. Lusby et al reported re-endothelialisation of several plaques,
and suggested that this is particularly likely when the time span between the onset of symp‐
toms and endarterectomy exceeds 3 weeks. [18]
The strength of the evidence from the NASCET trial has meant that most clinicians recognise
plaque cap ulceration as a risk factor for development of further carotid territory embolic
neurological events. Preoperative evidence of plaque cap ulceration has been included in
stroke risk calculators such as the Oxford Stroke Risk calculator. [19]
4. Composition of an atherosclerotic plaque
The raised lesion or fibro-lipid plaque is the archetypal lesion of atherosclerosis and compli‐
cations of this lesion (fissure and ulceration) form the basis of the vast majority of cases of
occlusive arterial disease. All atherosclerotic plaques share two basic morphological compo‐
nents:
Fibrous cap: a thick layer of fibrous connective tissue, which is significantly thicker and much
less cellular than the normal intima and contains lipid-filled macrophages, collagen and
smooth muscle cells;
Atheroma: A necrotic mass of lipid that forms the core of the lesion. Loss of continuity of the
endothelium is the main step in the progression of a plaque and increases the permeability of
the intima to lipoproteins, permits platelet-vessel wall interaction and release of growth factors
leading to formation of thrombus on the vessel wall.
Leahy demonstrated that various elements of the plaque are available as potential emboli. [20]
This includes the fibrous cap overlying complex plaques, the contents that include cholesterol
crystals, the breakdown products of intra-plaque haemorrhage, and fibrous or cartilaginous
material as well as calcified tissue. Hollenhorst showed the presence of cholesterol emboli in
the retinal artery of patients suffering from amaurosis fugax, in the form of bright plaques that
were seen in the extra-cranial carotid vessels. [21] Bock et al reported that soft plaques (lipid
laden and haemorrhagic plaque) behave in an unstable way and tend to ulcerate, whilst fibrous
or calcified plaques behave differently. [22]
Based on the natural history and pathological changes within the plaque the American Heart
Association (AHA) has classified atherosclerotic lesions [23] (table 1). This classification that
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has been modified by Virmani and Naghavi et al divides the atheromatous lesions into non-
atherosclerotic intimal lesions and progressive atherosclerotic plaques. [24, 25] The classifica‐
tion, although not particularly directed at the carotid atherosclerotic lesions, is however
applicable when classifying carotid plaques. Progressive atherosclerotic plaques (AHA plaque
types V and VI) are relevant in the setting of clinically significant carotid disease (figure-2).
Type I Adaptive Lesion: Intimal Smooth Muscle Cells (SMC)
Type II Fatty Streak, Foamy Macrophages and underlying SMCs
Type III Pre Atheroma, Intimal Macrophages, deeper pools of extracellular lipid
Type IV Atheroma (Fibrous Plaque), dense large extra cellular lipid core deep to intima, and close to media.
Type V Fibroatheroma, multiple layers of lipid core encased in a fibrous cap
Type VI
Complicated plaque:
VI a Disruption of the intimal surface
VI b Intra Plaque Haemorrhage
VI c Thrombosis related to the atherosclerotic plaque
Table 1. American Heart Association has classification of atherosclerotic lesions [23] (Circulation 1995;92: 1355-74)
Figure 2. American Heart Association Type VI (Complicated atherosclerotic lesion) obtained from a carotid endarter‐
ectomy specimen. (Br J Surg. 2001;88:945–950.)
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5. The concept of unstable atherosclerotic plaque
The  concept  that  a  sub-group  of  atherosclerotic  plaques  are  prone  to  embolisation  or
thrombosis is not new. As early as 1926, Benson postulated that coronary thrombosis results
from disruption of intima that exposes lipids to flowing blood. [26] Constantinides was the
first  to  establish conclusively that  plaque rupture was the immediate  cause of  coronary
thrombosis. [27] In a series of subsequent studies Davies et al established the importance
of  plaque  fissuring,  ulceration  and subsequent  thrombosis  in  the  development  of  acute
coronary syndromes.  [28-30]  Further clinical  and angiographic  work has led to progres‐
sion of  this  concept  and introduction of  thrombolytic  therapy in  the  treatment  of  coro‐
nary artery atherosclerosis. [31-34]
Atherosclerotic plaques that are prone to rupture are known to have certain cellular, molecular
and structural features. Notably these include an intense inflammatory process within the
plaque, angiogenesis, and intra-plaque haemorrhage with gradual thinning of the fibrous cap,
subsequent loss of plaque cap integrity and ulceration. [35] Burke et al defined a vulnerable
plaque in the coronary arteries as a lesion with a cap thickness of less than 65 µM [36]. Gertz
et al noted that the lipid cores were much larger in areas of atherosclerotic plaque disruption
than in lesions with intact surfaces. [37-38] Inflammatory activity within the plaque is associ‐
ated with plaque ulceration and has a role in pathogenesis of intimal damage. [39]
The evolution of atheroma is modulated by innate and adaptive immune responses which are
recognized histologically as presence of an inflammatory infiltrate within the lesion [40]. These
processes are responsible for replication and phenotypic change within the smooth muscle cell
from contractile to secretory which results in formation of plaque cap and lesion growth.
Intimal endothelial cell activation results in recruitment of macrophages and lymphocytes
(predominantly CD4 positive T-cells) into evolving lesion. [40] Activation of Th-1 T-cells is
known to initiate a potent inflammatory cascade which in turn leads to plaque instability [41].
Inflammatory cell infiltrate is a marker for plaque vulnerability. [42-47] Several factors such
as oxidized lipoproteins, infectious agents or auto-antigens (heat shock protein) have been
considered as the putative cause of the chronic inflammatory reaction in an atherosclerotic
plaque. [40] This in turn results in weakening of the connective tissue framework of the plaque.
[48, 49] Smooth muscles may help to counteract some of these effects by producing matrix
protein, collagen and inhibitors of matrix degrading enzymes known as metalloproteinases.
[50, 51] The net result of these two processes is thought to define whether or not the plaque
ruptures or remains contained by the fibrous cap.
6. Angiogenesis in carotid atherosclerotic lesions
Normal human intima is devoid of blood vessels, [52] however newly formed blood vessels
are often seen within atherosclerotic plaques [53-56] (figure-3). The presence and density of
these new blood vessels in carotid atherosclerotic lesions has been associated with the
histological features of plaque instability and intra-plaque haemorrhage as well as the
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development and timing of ipsilateral ischaemic or ocular events and presence of ipsilateral
cerebral infarction on computer tomography (CT) scanning. [57-62] Microarray gene chip
analysis revealed that the presence of newly formed vessels is associated with increased
angiogenic gene expression. [63, 64] These new blood vessels are weak and could be respon‐
sible for intraplaque haemorrhage. Moreover, the endothelial lining of these microvessels
express high levels of E-Selectin, ICAM-1, and VCAM-1, which indicates that these endothelial
cells are in an activated state. Activated endothelial cells act as local site of inflammatory cell
recruitment into the atherosclerotic plaque, perpetuating the inflammatory process within the
lesion and contribute to plaque destabilization. [65-69]
7. Plaque haemorrhage
Haemorrhage is a common feature of unstable carotid atherosclerotic lesions. [68-72] Intra-
plaque haemorrhage has been associated with the development and growth of the necrotic
plaque core, rapid changes in plaque volume, development of plaque instability, and ischaemic
neurological events. [73-76]
The origin of plaque haemorrhage is uncertain. It has been suggested that it may occur from
fissures within the plaque cap. [76] Alternatively the new blood vessels within the athero‐
sclerotic plaque may represent the first site of morphologic change that leads to intra-plaque
haemorrhage; features such as microvessel density and perivascular inflammatory infiltrate
have been associated with the presence and quantity of intra-plaque haemorrhage. [55, 77, 78]
Structural:





Increased macrophage density and activity
T Lymphocyte accumulation near site of rupture
Increased Neovascularity
Reduced Smooth muscle cell density
Increased number and activity of mast cells
Expression of markers of inflammatory activation
Molecular
Matrix Metalloproteinase Secretion
Increased Tissue Factor Expression
Table 2. Features of Rupture prone (Unstable) Plaques [40]
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There is ample clinical and histological evidence that carotid atherosclerotic plaques with large
necrotic lipid core, thin plaque cap or ulceration, dense inflammatory infiltrate, intra-plaque
haemorrhage and angiogenesis are vulnerable to rupture and development of ischaemic
neurological and ocular events. In vivo identification of these changes within carotid athero‐
sclerotic plaques gives these findings clinical significance in the context of patients with
significant carotid atherosclerosis. For over two decades, non-invasive imaging modalities
such as duplex ultrasound and magnetic resonance imaging have been in clinical use. They
have been used for the measurement of internal carotid artery stenosis. [79-81] These imaging
modalities can also be used to study morphological changes associated with plaque instability
and development of ischaemic neurological events. [82-85]
8. Duplex ultrasound assessment of carotid plaque morphology
Duplex ultrasound is arguably the most important imaging modality for preoperative
assessment of patients with carotid atherosclerotic disease. It is non-invasive, relatively
inexpensive and very accurate at identification of significant ICA stenosis. [87-92] In measuring
the degree of stenosis, the flow and velocity characteristics assessed by colour flow Doppler
are utilized. Duplex devices also generate high resolution B-mode ultrasound images of the
atherosclerotic lesion. These images do not contribute significantly to the assessment of carotid
Figure 3. New blood vessels in a carotid atherosclerotic plaque. (Ann Vasc Surg 2008; 22(2): 266–272.)
Carotid Plaque Morphology: Plaque Instability and Correlation with Development of Ischaemic Neurological Events
http://dx.doi.org/10.5772/57254
91
artery stenosis. However the B-mode ultrasound image can be used to assess morphologic
characteristics of an atherosclerotic lesion. It has been known for some time that plaques that
have low echogenicity (appear dark on Duplex ultrasound) or a high degree of heterogeneity
are associated with histologic characteristics of plaque instability, ipsilateral neurological or
ocular events, [93] CT evidence of carotid territory cerebral infarction or evidence of emboli‐
sation on trans-cranial ultrasound. [94] These ultrasound characteristics can be assessed
subjectively and classified by a trained observer.
B-mode ultrasound assessment of atherosclerotic plaque morphology started some 30 years
ago. Reilly et al recognised two distinct types of carotid atherosclerotic lesion. The first was
termed homogenous and was defined as lesion with uniformly high or medium level echoes.
Histologically, homogenous plaques are fibrous lesions. [95] The second type was termed
heterogeneous and was defined as plaque with high, medium and low level echoes. [95]
Histologically heterogeneous plaques contain variable amounts of intra-plaque haemorrhage,
lipids, cholesterol crystal and a loose stroma. A further refinement of subjective assessment of
plaque morphology was the Gray-Wheal classification method (table-3). [96] In the Cardio‐
vascular Health Study, which enrolled 5,201 individuals aged 65 years and over without prior
cerebrovascular symptoms, and followed them for an average of 3.3 years demonstrated a
significantly increased incidence of stroke in individuals who had echo-lucent plaques. [97]
Plaque Type Ultrasound characteristics
Type-1 Predominantly echolucent with a thin echogenic cap
Type-2 Intermediate echolucent lesions with small areas of echogenicity
Type-3 Intermediate echogenic lesions with small areas of echolucency (<25%)
Type-4 Uniformly echogenic lesions (equivalent to homogenous).
Table 3. Gray-Wheal Classification of atherosclerotic plaques
Subjective observer dependent assessment of plaque morphology, whilst useful, is limited by
high inter- and intra-observer variability, significantly limiting its clinical application. [98-99]
Echogenicity and heterogeneity of an atherosclerotic plaque can be objectively assessed using
image analysis techniques through the measurement of median grey scale (GS) value of the
ultrasound image, percentage of echo-lucent pixels and entropy in GS characteristics of the
lesion(figure-4). [99-103] In order to remove variability associated with acquisition of the
ultrasound image, the US images are normalised using linear scaling so that the adventitia
would have a grey scale median value of 185-195 and blood 0-5. Plaques with a low GS median
were associated with a significantly higher annual risk of stroke. [99-104]
Interestingly, although characterisation of the internal structure of the plaque assessed by
image analysis correlates closely with clinical symptoms, the correlation between computer‐
ised assessment of plaque morphology and histological features of the lesion is less strong. [94]
This indicates that values such as GS median represent a median value of the whole athero‐
sclerotic area and do not necessarily reflect the presence of particular regional components.
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The use of stratified GS median measurements which create a profile of the regional GS median
as a function of distance from plaque surface combined with colour mapping correlates better
with the presence of various histopathological components and identify determinants of
plaque instability with a high degree of accuracy. [94]
Figure 4. Calculation of Grey Scale Median of a hypo-echoic plaque. (Swiss Med 2005; 135:635–643.)
9. Magnetic resonance imaging assessment of plaque morphology
Magnetic resonance imaging (MRI) is a promising modality for characterisation of carotid
plaque morphology and assessment of composition of atherosclerotic plaques. It can accu‐
rately identify the presence of ulcerated or thin plaque cap, [105-107] quantify intra-plaque
haemorrhage [105-107], or the presence of a large necrotic plaque core [105-107]. Serial MRI
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examinations in asymptomatic patients with moderate (50-70-percent) ICA stenosis have
revealed correlation between these plaque findings and development of subsequent ipsilateral
ocular and ischaemic neurological events [108] (Figure-5).
Figure 5. Identification of intra-plaque haemorrhage using high spatial resolution, multi-contrast MRI image. (JACC
Cardiovasc Imaging. 2009; 2:883-96.)
One of the strengths of MRI is the availability of multi-contrast weighted protocols. The most
common application of carotid MRI remains the acquisition of an angiogram which uses a
bright blood sequence using a 3-dimensional time of flight sequence. This attenuates the signal
from stationary (plaque) tissues. Black blood sequences eliminate the luminal signal and help
to characterise plaque morphology. [105-109] Combining the information, multiple-contrast
weightings can be used to identify all plaque components. [105-110] Plaque compositional
characteristics can be assessed using automatic classifiers such as morphology enhanced
probabilistic plaque segmentation (MEPPS) algorithms with a high degree of accuracy
(Figure-6). [111, 112] Administration of gadolinium-DTPA together with T1-weighted
sequences in addition to bright blood time of flight sequence can be used to create maximal
intensity projection (MIP) images for measurement of the degree of ICA stenosis [105-107] and
accurately measure the thickness of plaque cap in relation to the necrotic core volume. [105-107]
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Figure 6. Automated segmentation of bright–and black-blood, high-spatial resolution, Multi-contrast in vivo MR im‐
ages compared with histological characteristics of plaque. (JACC Cardiovasc Imaging. 2009; 2:883-96.)
High resolution MRI can identify and age intra-plaque haemorrhage. [113-115] Prospective
serial MRI studies have demonstrated that haemorrhage in atherosclerotic plaques is associ‐
ated with sudden increases in plaque volume, necrotic core, and progression of degree of
stenosis. [115]
In addition to Duplex and MRI, other modalities such as fludeoxyglucose (FDG) positron
emission tomography (PET) CT scanning has been used to assess the level of metabolic activity
in carotid atherosclerotic plaque. This is used in turn as a surrogate marker of plaque insta‐
bility.
PET CT scanning has shown some promise as a tool for assessment of plaque instability. [116]
However it is unlikely to gain mainstream applicability due to its limited availability, expense,
and the significant exposure to ionising radiation (meaning serial assessments are not possible)
and availability of non-invasive accurate imaging modalities to assess plaque morphology.
10. Conclusion
Over the last 20 years the advances in technology have led to the evolution of non-invasive
imaging modalities with high spatial resolution. The application of this technology in the
assessment of carotid plaque morphology has advanced our understanding of the natural
history of atherosclerotic lesions more than the assessment of histological characteristics of
atherosclerotic plaques. Consequently for the first time, plaque morphology could be assessed
against the two functions that ultimately matter the most: time and occurrence of future
embolic ischaemic events.
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New and continuing advances in MRI technology such as higher field strength, phased-array
coils, and the application of 3-dimensional and contrast enhanced ultrasound will provide
even more tools for assessment of carotid plaque morphology. Gradual application of these
modalities in clinical practice will help clinicians select patients with significant ICA stenosis
who are likely to benefit from carotid intervention prior to occurrence of ischaemic neurolog‐
ical events.
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